Page last updated: 2024-08-24

tiludronic acid and Gait Disorders, Animal

tiludronic acid has been researched along with Gait Disorders, Animal in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Allen, K; Denoix, JM; Mitchell, RD; Parkin, T; Tischmacher, A; Wilford, S1
Gillett, AN; McNulty, MA; Mitchell, CF; Richbourg, HA1
Payton, ME; Schoonover, MJ; Sippel, KM; Whitfield, CT; Young, JM1
Holbrook, TC; Payton, ME; Schoonover, MJ; Sippel, KM; Whitfield, CT1
Gough, MR; Smith, RK; Thibaud, D1
Denoix, JM; Riccio, B; Thibaud, D1

Trials

4 trial(s) available for tiludronic acid and Gait Disorders, Animal

ArticleYear
Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
    BMC veterinary research, 2018, Mar-20, Volume: 14, Issue:1

    Topics: Animals; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Clodronic Acid; Diphosphonates; Horse Diseases; Horses; Lameness, Animal; Osteogenesis; Pilot Projects

2018
Quantitative assessment of intravenous regional limb perfusion of tiludronate as an adjunctive treatment for lameness caused by navicular syndrome in horses.
    American journal of veterinary research, 2018, Volume: 79, Issue:12

    Topics: Administration, Intravenous; Animals; Bone Density Conservation Agents; Diphosphonates; Female; Foot Diseases; Forelimb; Gait; Horse Diseases; Horses; Lameness, Animal; Male; Random Allocation; Syndrome; Tarsal Bones

2018
Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial.
    Equine veterinary journal, 2010, Volume: 42, Issue:5

    Topics: Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Hindlimb; Horse Diseases; Horses; Lameness, Animal; Male; Osteoarthritis

2010
Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial.
    Equine veterinary journal, 2003, Volume: 35, Issue:4

    Topics: Animals; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Foot Diseases; Hoof and Claw; Horse Diseases; Horses; Injections, Intravenous; Lameness, Animal; Male; Osteitis; Treatment Outcome; Video Recording

2003

Other Studies

2 other study(ies) available for tiludronic acid and Gait Disorders, Animal

ArticleYear
Retrospective Analysis of the Use of Tiludronate in Equine Practice: Safety on 1804 Horses, Efficacy on 343 Horses.
    Journal of equine veterinary science, 2022, Volume: 115

    Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Horse Diseases; Horses; Lameness, Animal; Retrospective Studies

2022
Quantitative assessment of two methods of tiludronate administration for the treatment of lameness caused by navicular syndrome in horses.
    American journal of veterinary research, 2016, Volume: 77, Issue:2

    Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Forelimb; Horse Diseases; Horses; Injections, Intravenous; Lameness, Animal

2016